Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implantable cardiac defibrillators.

R W Peters1, M R Gold

  • 1Department of Medicine, Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

The Medical Clinics of North America
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal anesthesia in the percutaneous fixation of fragility fractures of the pelvis.

Trauma case reports·2022
Same author

Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2018
Same author

Two-stage treatment in patients with patients with high-energy femoral fractures does not lead to an increase in deep infectious complications: a propensity score analysis.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2017
Same author

Implementation of an acute surgical admission ward.

The British journal of surgery·2014
Same author

The Rap GTPases regulate the migration, invasiveness and in vivo dissemination of B-cell lymphomas.

Oncogene·2009
Same author

Predicting geographical variations in behavioural risk factors: an analysis of physical and mental healthy days.

Journal of epidemiology and community health·2004
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Implantable cardioverter defibrillators (ICDs) have evolved significantly, improving patient tolerance and reducing sudden cardiac death. Future research will expand ICD use and assess cost-effectiveness.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • Sudden cardiac death (SCD) remains a significant public health concern, with nearly 400,000 deaths annually in the US.
  • Early implantable cardioverter defibrillators (ICDs) had limitations, including invasive epicardial leads and abdominal generator placement.
  • Advancements in ICD technology have focused on improving patient outcomes and device efficacy.

Purpose of the Study:

  • To review the evolution of implantable cardioverter defibrillators (ICDs).
  • To highlight key technological advancements enhancing device performance and patient tolerance.
  • To discuss the future directions and expanding indications for ICD therapy.

Main Methods:

  • Review of historical development and technological refinements in ICDs.

Related Experiment Videos

  • Analysis of improvements in lead systems, generator placement, and waveform technology.
  • Discussion of current and planned clinical trials evaluating ICDs.

    • Main Results:

    • Transvenous leads and pectoral implantation have replaced earlier systems, improving patient comfort and reducing invasiveness.
    • Biphasic waveforms, enhanced sensing algorithms, and antitachycardia pacing have significantly improved device effectiveness and patient tolerance.
    • Ongoing research aims to broaden the application of ICDs and evaluate their economic viability.

    Conclusions:

    • Implantable cardioverter defibrillators (ICDs) have undergone substantial technological evolution, leading to improved patient tolerance and reduced sudden cardiac death.
    • Continued research and clinical trials are expected to expand the indications for ICDs and address cost-effectiveness.
    • The ongoing development of ICDs signifies a commitment to advancing cardiac arrhythmia management and patient survival.